The Insight Corner Hub: A Comprehensive Review of Epidemiology, Treatment, Prevalence, and Factors Influencing Drug-Related Problems among Patients with Type 2 Diabetes Mellitus and Hypertension in Africa and Rwanda

Abstract

Type 2 diabetes mellitus (T2DM) and hypertension are two common chronic conditions with a significant burden in Africa and specifically in Rwanda. This article presents a comprehensive review of the epidemiology, treatment, prevalence, and factors influencing drug-related problems among patients with T2DM and hypertension in Africa and Rwanda. Understanding these aspects is crucial for healthcare providers and policymakers in effectively managing and preventing complications associated with these conditions.

Introduction

T2DM and hypertension are major global health concerns, and their coexistence significantly increases the risk of cardiovascular diseases and other complications. In Africa, the prevalence of T2DM and hypertension has been rising steadily due to factors like urbanization, sedentary lifestyle, unhealthy diets, and genetic predisposition. Rwanda, a landlocked country in East Africa, is no exception to this trend. Therefore, it is essential to investigate the epidemiology, treatment practices, and factors influencing drug-related problems among patients with T2DM and hypertension in Africa, with a focus on Rwanda.

Methods

This review incorporates a comprehensive analysis of relevant studies and literature published between 1995 to 2023 from various databases, including PubMed, Google Scholar, and local sources. The search terms included "T2DM," "hypertension," "Africa," "Rwanda," "epidemiology," "treatment," "prevalence," and "drug-related problems."

Epidemiology

The prevalence of T2DM and hypertension in Africa is alarmingly high, affecting both urban and rural populations. Various risk factors, such as obesity, lack of physical activity, unhealthy diets, and genetics, contribute to the increasing burden of these chronic conditions. Rwanda, in particular, is experiencing a rapid epidemiological transition, resulting in a surge in non-communicable diseases, including T2DM and hypertension.

Treatment

The management of T2DM and hypertension involves lifestyle modifications, pharmacotherapy, and regular monitoring. In Africa, including Rwanda, there are numerous challenges in providing adequate treatment and care to patients with these conditions. Limited access to healthcare facilities, high medication costs, poor adherence, and inadequate healthcare infrastructure contribute to suboptimal treatment outcomes.

Prevalence

Studies have identified a high prevalence of T2DM and hypertension in Africa and Rwanda. However, underdiagnosis and undertreatment remain significant issues. Lack of awareness, limited screening programs, and weak health systems contribute to the low identification of patients with these conditions. This emphasizes the urgent need for comprehensive screening and early detection strategies.

Factors Influencing Drug-Related Problems

Several factors influence drug-related problems among patients with T2DM and hypertension in Africa and Rwanda. These include socioeconomic factors, limited healthcare resources, cultural beliefs and practices, lack of patient education, language barriers, and poor medical adherence. Addressing these factors is crucial to improving treatment outcomes and reducing the burden of disease.

Read also: A Comprehensive Review of Epidemiology, Treatment, Prevalence, and Factors Influencing Drug-Related Problems among Patients with Type 2 Diabetes Mellitus and Hypertension

Conclusion

T2DM and hypertension pose significant health challenges in Africa and Rwanda. Understanding the epidemiology, treatment practices, prevalence, and factors influencing drug-related problems is essential for effective management and prevention. Healthcare providers and policymakers should focus on implementing comprehensive screening programs, improving access to healthcare, promoting patient education, and addressing socioeconomic barriers to ensure optimal outcomes for patients with T2DM and hypertension in Africa, with particular consideration for the context in Rwanda.

Bibliography (sample):

1. Abrahams-Gessel S, Denman CA, Montano CM, Gaziano TA, Levitt NS, Puoane T. Predictors of hypertension in a population of black South Africans: results from the demographic and health survey. J Hum Hypertens. 2012;26(2):126-132. doi:10.1038/jhh.2011.7

2. Akinyemi JO, Akinwusi PO, Babatunde OA, et al. Hypertension prevalence and its etiologic risk factors in adult Nigerians: a community-based survey. Ethiop J Health Sci. 2016;26(2):147-156. doi:10.4314/ ejhs.v26i2.6

3. Atun R, Davies JI, Gale EAM, et al. Diabetes in sub-Saharan Africa: from clinical care to health policy. Lancet Diabetes Endocrinol. 2017;5(8):622-667. doi:10.1016/S2213-8587(17)30181-X

4. Beran D, Yudkin JS, de Courten M. Access to care for patients with insulin-requiring diabetes in developing countries: case studies of Mozambique and Zambia. Diabetes Care. 2005;28(9):2136-2140. doi:10.2337/diacare.28.9.2136

5. Geldsetzer P, Manne-Goehler J, Marcus ME, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults. Lancet. 2019;394(10199):652-662. doi:10.1016/S0140-6736(19)30955-9

6. Hall V, Thomsen RW, Henriksen O, Lohse N. Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review. BMC Public Health. 2011;11(1):564. doi:10.1186/1471-2458-11-564

7. Irazola VE, Gutierrez L, Bloomfield G, et al. Hypertension prevalence, awareness, treatment, and control in selected LMIC communities: results from the NHLBI/UHG Network of Centers of Excellence for Chronic Diseases. Glob Heart. 2016;11(1):47-59. doi:10.1016/j.gheart.2015.12.012

8. Kayima J, Wanyenze RK, Katamba A, Leontsini E, Nuwaha F. Hypertension awareness, treatment and control in Africa: a systematic review. BMC Cardiovasc Disord. 2013;13(1):54. doi:10.1186/1471-2261-13-54

9. Mutyambizi C, Pavlova M, Chola L, Hongoro C, Groot W. Cost and predictors of loss to follow-up in diabetes mellitus type 2 patients attending a tertiary care clinic in South Africa. Int J Environ Res Public Health. 2019;16(6):931. doi:10.3390/ijerph16060931

10. Nguemo JD-N, Atanga EN, Sobngwi E, et al. The prevalence of hypertension in people with diabetes mellitus in sub-Saharan Africa: a systematic review and meta-analysis. J Hypertens. 2019;37(12):2348-2356. doi:10.1097/HJH.0000000000002204

11. Nzayisenga, J., Ngomi, N. N., & Nyiligira, J. (2020). Drug-related problems among type II diabetes mellitus patients with hypertension: a cross-sectional study.